{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:08:55Z","timestamp":1790791735995,"version":"4.1.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>To determine the feasibility and impact of real-time anti-factor Xa (aFXa) level monitoring and enoxaparin dose adjustment in orthopaedic trauma. To examine the adequacy of standard fixed-dose enoxaparin chemoprophylaxis and to examine whether patient-specific factors influence enoxaparin metabolism.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Prospective cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Academic Level-I trauma center.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>Postoperative adult orthopaedic trauma patients undergoing acute fracture or nonunion surgery of the pelvis, acetabulum, or lower extremity placed on 30 mg of enoxaparin twice daily.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Intervention:<\/jats:title>\n            <jats:p>Peak steady-state aFXa levels were drawn with a goal range of 0.2\u20130.4 IU\/mL. Patients with out-of-range levels underwent a 10-mg dose adjustment followed by repeat aFXa draws.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Main Outcome Measures:<\/jats:title>\n            <jats:p>Peak and trough aFXa levels, 90-day venous thromboembolism, and bleed events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of 109 enrolled patients, 43% had inadequate initial peak aFXa levels (aFXa &lt; 0.2 IU\/mL) with standard dosing. Higher gross weight, acetabular surgery, and operation length predicted low aFXa levels (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001, 0.006, 0.004, respectively). Dose adjustment increased the proportion of patients with in-range aFXa levels from 53.2% to 87.8% (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). Patients with low aFXa levels during hospitalization or at discharge had significantly higher 90-day deep vein thrombosis and pulmonary embolism rates compared to those with adequate aFXa levels (deep vein thrombosis 12% vs. 1.36%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.023, pulmonary embolism 8% vs. 0%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.027). There were no major bleed events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Patients receiving inadequate enoxaparin chemoprophylaxis were at significantly increased risk of 90-day venous thromboembolism. Standard fixed-dose enoxaparin provided inadequate chemoprophylaxis in 43% of postoperative orthopaedic trauma patients, which significantly improved with dose adjustment. Weight, acetabular surgery, and operation length predicted inadequate enoxaparin prophylaxis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Level of Evidence:<\/jats:title>\n            <jats:p>Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bot.0000000000001563","type":"journal-article","created":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T17:19:28Z","timestamp":1561223968000},"page":"570-576","source":"Crossref","is-referenced-by-count":17,"title":["Underdosing of Prophylactic Enoxaparin Is Common in Orthopaedic Trauma and Predicts 90-Day Venous Thromboembolism"],"prefix":"10.1097","volume":"33","author":[{"given":"Daniel L.","family":"Jones","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Utah, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Jones","sequence":"additional","affiliation":[{"name":"UC San Diego, La Jolla, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kory I.","family":"Fleming","sequence":"additional","affiliation":[{"name":"Division of Plastic Surgery, University of Utah, Salt Lake City, UT; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Higgins","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Utah, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Rothberg","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, University of Utah, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Study Design and Biostatistics Center, Division of Epidemiology, University of Utah, Salt Lake City, UT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Pannucci","sequence":"additional","affiliation":[{"name":"Division of Plastic Surgery, University of Utah, Salt Lake City, UT; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"6 suppl","key":"R2-20230828","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest"},{"key":"R3-20230828","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJM199412153312401","article-title":"A prospective study of venous thromboembolism after major trauma","volume":"331","author":"Geerts","year":"1994","journal-title":"N Engl J Med."},{"key":"R4-20230828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5435\/JAAOS-23-01-1","article-title":"Venous thromboembolism in orthopaedic trauma","volume":"23","author":"Scolaro","year":"2015","journal-title":"J Am Acad Orthop Surg."},{"key":"R5-20230828","first-page":"261","article-title":"Prophylaxis against deep-vein thrombosis following trauma: a prospective, randomized comparison of mechanical and pharmacologic prophylaxis","volume":"88","author":"Stannard","year":"2006","journal-title":"J Bone Joint Surg Am."},{"issue":"2 suppl","key":"R6-20230828","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"key":"R7-20230828","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2106\/JBJS.9408.ebo746","article-title":"American Academy of Orthopaedic Surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty","volume":"94","author":"Jacobs","year":"2012","journal-title":"J Bone Joint Surg Am."},{"key":"R8-20230828","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1097\/BOT.0000000000000387","article-title":"Orthopaedic trauma association evidence based quality value and safety committee. Venous thromboembolism prophylaxis in orthopaedic trauma patients: a survey of OTA member practice patterns and OTA expert panel recommendations","volume":"29","author":"Sagi","year":"2015","journal-title":"J Orthop Trauma."},{"key":"R9-20230828","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00005373-200207000-00032","article-title":"Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group","volume":"53","author":"Rogers","year":"2002","journal-title":"J Trauma."},{"key":"R10-20230828","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-121-2-199407150-00001","article-title":"Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial Group","volume":"121","author":"Spiro","year":"1994","journal-title":"Ann Intern Med."},{"key":"R12-20230828","first-page":"799","article-title":"College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban","volume":"122","author":"Laposata","year":"1998","journal-title":"Arch Pathol Lab Med."},{"key":"R13-20230828","first-page":"940","article-title":"The relationship between anti-factor Xa level and LMWH to prevent DVT after hip replacement","volume":"62","author":"Levine","year":"1989","journal-title":"J Thromb Haemotol."},{"key":"R14-20230828","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/TA.0b013e3182788fa7","article-title":"Dose adjusting enoxaparin is necessary to achieve adequate venous thromboembolism prophylaxis in trauma patients","volume":"74","author":"Costantini","year":"2013","journal-title":"J Trauma Acute Care Surg."},{"key":"R15-20230828","first-page":"1557","article-title":"Enoxaparin dose adjustment is associated with low incidence of venous thromboembolic events in acute burn patients","volume":"71","author":"Lin","year":"2011","journal-title":"J Trauma."},{"key":"R16-20230828","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/BCR.0b013e3182a2a855","article-title":"Evaluation of an enoxaparin dosing calculator using burn size and weight","volume":"34","author":"Faraklas","year":"2013","journal-title":"J Burn Care Res."},{"key":"R17-20230828","first-page":"874","article-title":"Standard prophylactic enoxaparin dosing leads to inadequate anti-Xa levels and increased deep venous thrombosis rates in critically ill trauma and surgical patients","volume":"68","author":"Malinoski","year":"2010","journal-title":"J Trauma."},{"key":"R18-20230828","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1186\/cc12684","article-title":"A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients: a double-blinded, randomised controlled trial","volume":"17","author":"Robinson","year":"2013","journal-title":"Crit Care."},{"key":"R19-20230828","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.soard.2007.11.010","article-title":"Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity","volume":"4","author":"Borkgren-Okonek","year":"2008","journal-title":"Surg Obes Relat Dis."},{"key":"R20-20230828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/BCR.0b013e318204b346","article-title":"Enoxaparin and antifactor Xa levels in acute burn patients","volume":"32","author":"Lin","year":"2011","journal-title":"J Burn Care Res."},{"key":"R21-20230828","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.amjsurg.2013.10.005","article-title":"Alternative dosing of prophylactic enoxaparin in the trauma patient: is more the answer?","volume":"206","author":"Kopelman","year":"2013","journal-title":"Am J Surg."},{"key":"R22-20230828","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/PRS.0000000000003159","article-title":"Inadequate enoxaparin dosing predicts 90-day venous thromboembolism risk among plastic surgery inpatients: an examination of enoxaparin pharmacodynamics","volume":"139","author":"Pannucci","year":"2017","journal-title":"Plast Reconstr Surg."},{"key":"R23-20230828","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/BCR.0b013e3182a2a9f8","article-title":"Enoxaparin and antifactor Xa levels in pediatric acute burn patients","volume":"34","author":"Brown","year":"2013","journal-title":"J Burn Care Res."},{"key":"R24-20230828","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1345\/aph.1Q313","article-title":"Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients","volume":"45","author":"Ludwig","year":"2011","journal-title":"Ann Pharmacother."},{"key":"R25-20230828","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/000313481508100625","article-title":"Prospective evaluation of weight-based prophylactic enoxaparin dosing in critically ill trauma patients: adequacy of AntiXa levels is improved","volume":"81","author":"Nunez","year":"2015","journal-title":"Am Surg."},{"key":"R26-20230828","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.thromres.2009.02.003","article-title":"Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients","volume":"125","author":"Rondina","year":"2010","journal-title":"Thromb Res."},{"key":"R27-20230828","doi-asserted-by":"crossref","first-page":"70e78","DOI":"10.1016\/j.disamonth.2005.02.003","article-title":"Thrombosis risk assessment as a guide to quality patient care","volume":"51","author":"Caprini","year":"2005","journal-title":"Dis Mon."},{"key":"R28-20230828","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/SLA.0b013e3182519ccf","article-title":"Identifying patients at high risk for venous thromboembolism requiring treatment after outpatient surgery","volume":"255","author":"Pannucci","year":"2012","journal-title":"Ann Surg."},{"key":"R30-20230828","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/TA.0000000000001663","article-title":"Relation of antifactor-Xa peak levels and venous thromboembolism after trauma","volume":"83","author":"Karcutskie","year":"2017","journal-title":"J Trauma Acute Care Surg."},{"key":"R31-20230828","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/TA.0000000000001193","article-title":"Anti-Xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients","volume":"81","author":"Singer","year":"2016","journal-title":"J Trauma Acute Care Surg."},{"key":"R32-20230828","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jamasurg.2016.1662","article-title":"Association between enoxaparin dosage adjusted by anti-factor Xa trough level and clinically evident venous thromboembolism after trauma","volume":"151","author":"Ko","year":"2016","journal-title":"JAMA Surg."},{"key":"R33-20230828","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jamcollsurg.2014.01.046","article-title":"Inadequate venous thromboembolism risk stratification predicts venous thromboembolic events in surgical intensive care unit patients","volume":"218","author":"Pannucci","year":"2014","journal-title":"J Am Coll Surg."},{"key":"R34-20230828","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/TA.0000000000001655","article-title":"Venous thromboembolism after major venous injuries: competing priorities","volume":"83","author":"Frank","year":"2017","journal-title":"J Trauma Acute Care Surg."},{"key":"R35-20230828","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.thromres.2013.10.005","article-title":"Anti-Xa activity after enoxaparin prophylaxis in hospitalized patients weighing less than fifty-five kilograms","volume":"132","author":"Rojas","year":"2013","journal-title":"Thromb Res."},{"key":"R36-20230828","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.amjsurg.2013.07.020","article-title":"Weight-based enoxaparin dosing for venous thromboembolism prophylaxis in the obese trauma patient","volume":"206","author":"Bickford","year":"2013","journal-title":"Am J Surg."},{"key":"R37-20230828","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/TA.0000000000000087","article-title":"Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients","volume":"76","author":"Droege","year":"2014","journal-title":"J Trauma Acute Care Surg."},{"key":"R38-20230828","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijsu.2018.01.023","article-title":"Trauma patients with lower extremity and pelvic fractures: should anti-factor Xa trough level guide prophylactic enoxaparin dose?","volume":"51","author":"Dhillon","year":"2018","journal-title":"Int J Surg."},{"key":"R39-20230828","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/ajh.23228","article-title":"Prospective comparison of three enoxaparin dosing regimens to achieve target anti-factor Xa levels in hospitalized, medically ill patients with extreme obesity","volume":"87","author":"Freeman","year":"2012","journal-title":"Am J Hematol."},{"key":"R40-20230828","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/014860717900300609","article-title":"Metabolic response to injury and illness: estimation of energy and protein needs from indirect calorimetry and nitrogen balance","volume":"3","author":"Long","year":"1979","journal-title":"JPEN J Parenter Enteral Nutr."},{"key":"R41-20230828","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1042\/bj0241244","article-title":"The disturbance of metabolism produced by bony and non-bony injury, with notes on certain abnormal conditions of bone","volume":"24","author":"Cuthbertson","year":"1930","journal-title":"Biochem J."},{"key":"R42-20230828","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3928\/0147-7447-20050201-16","article-title":"Patient compliance with outpatient prophylaxis: an observational study","volume":"28","author":"Colwell","year":"2005","journal-title":"Orthopedics"},{"key":"R43-20230828","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/PRS.0b013e31818dbffd","article-title":"Efficacy and safety of venous thromboembolism prophylaxis in highest risk plastic surgery patients","volume":"122","author":"Seruya","year":"2008","journal-title":"Plast Reconstr Surg."}],"container-title":["Journal of Orthopaedic Trauma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000001563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T06:54:10Z","timestamp":1693205650000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOT.0000000000001563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/bot.0000000000001563","relation":{},"ISSN":["0890-5339"],"issn-type":[{"value":"0890-5339","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}